Evaluation of Body-worn Multimodal Hand Hygiene System. Impact on Health-Care Associated Infections

Real Time Deployment of Multimodal Personal Dispenser Hand Hygiene System in a Multidisciplinary Intensive Care Unit.

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01050608

Acronym

Sprixx-ICU

Enrollment

2954

Registered

2010-01-15

Start date

2007-12-31

Completion date

2011-01-31

Last updated

2011-06-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nosocomial Infection

Keywords

Alcohol Rub, Hand Hygiene, Provider Feedback, Health Care Associated Infections

Brief summary

Evaluate the efficacy of a multimodal hand hygiene system in the intensive care unit environment and evaluate any impact on health care associated infections.

Detailed description

Deploy and utilize a novel body worn hand hygiene system that incorporates provider and group specific feedback allowing hand hygiene to occur directly within the patient environment. We hypothesize that by improving provider hand hygiene we will reduce health-care associated infection rates.

Interventions

DEVICEBody worn alcohol gel dispenser

Records hand hygiene events of provider and tabulates on the group level.

DRUG62% ethanol based hand cleanser

CDC based guidelines with regard to utilization in the health care environment the nest

BEHAVIORALEducational component with regard to teaching CDC guidelines

12 minute education prior to deploying device for all providers.

BEHAVIORALProvider and group feedback

Provide feedback with regard to expected hand hygiene goals to providers and reported anonymous group results based on recorded information.

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Healthy volunteers

Yes

Inclusion criteria

* All ICU patients

Exclusion criteria

* Patient is not in an ICU at our Institution

Design outcomes

Primary

Measure	Time frame
Reduction in healthcare associated infections (CRBSI and VAP)	2 years

Secondary

Measure	Time frame
Time to infections Hospital mortality Length of stay	2 years

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026